Target Name: TFDP3
NCBI ID: G51270
Review Report on TFDP3 Target / Biomarker Content of Review Report on TFDP3 Target / Biomarker
TFDP3
Other Name(s): transcription factor Dp family member 3 | HCA661 | hepatocellular carcinoma-associated antigen 661 | TFDP3_HUMAN | E2F-like | CT30 | DP4 | Hepatocellular carcinoma-associated antigen 661 | cancer/testis antigen 30 | MGC161639 | E2F-like protein | Transcription factor Dp family member 3 | Cancer/testis antigen 30

TFDP3: A Promising Drug Target and Potential Biomarker for Transcription Factor Dp Family Member 3

Abstract:
TFDP3, a member of the Dp family, is a non-coding RNA molecule that plays a crucial role in various cellular processes. Research has shown that TFDP3 can act as a drug target and may also serve as a biomarker for various diseases. This article aims to provide an overview of TFDP3, its functions, and potential as a drug target and biomarker.

Introduction:
Transcription factor Dp family member 3 (TFDP3) is a non-coding RNA molecule that belongs to the Dp family of RNA binding proteins. It is characterized by a conserved N-terminal domain, a conserved C-terminal domain, and a unique R -loop region that is unique among RNA binding proteins. TFDP3 has been shown to play a crucial role in various cellular processes, including cell growth, differentiation, and apoptosis.

TFDP3 functions as a drug target:
Several studies have shown that TFDP3 can act as a drug target for various diseases. For example, TFDP3 has been shown to be a potential drug target for cancer, including breast cancer, lung cancer, and colorectal cancer. Additionally, TFDP3 has has been shown to be involved in the regulation of cell apoptosis, which is a critical process in cancer progression.

TFDP3 may also serve as a biomarker for various diseases:
TFDP3 has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. This suggests that TFDP3 may be a useful biomarker for various diseases. For example, TFDP3 has been shown to be involved in the regulation of cancer progression, and may be used as a biomarker for cancer diagnosis and treatment.

TFDP3's unique structure and function:
TFDP3 is a non-coding RNA molecule that has a unique structure. It has a conserved N-terminal domain that is similar to other RNA binding proteins, a conserved C-terminal domain that is also similar to other RNA binding proteins, and a unique R-loop region that is unique among RNA binding proteins. The R-loop region of TFDP3 is thought to play a crucial role in its unique function.

Conclusion:
TFDP3 is a non-coding RNA molecule that belongs to the Dp family of RNA binding proteins. It has been shown to play a crucial role in various cellular processes, including cell growth, differentiation, and apoptosis. Additionally, TFDP3 has been shown to be involved in the regulation of cancer progression and may serve as a useful biomarker for various diseases. Further research is needed to fully understand the unique functions of TFDP3 and its potential as a drug target and biomarker.

Protein Name: Transcription Factor Dp Family Member 3

Functions: Competitive inhibitor of E2F-mediated transactivation activity. Impairs E2F-mediated cell-cycle progression from G(1) to S phase

The "TFDP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TFDP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex | TFIP11 | TFIP11-DT | TFPI | TFPI2 | TFPT | TFR2 | TFRC | TG | TGDS | TGFA | TGFA-IT1 | TGFB1 | TGFB1I1 | TGFB2 | TGFB2-AS1 | TGFB3 | TGFBI | TGFBR1 | TGFBR2 | TGFBR3 | TGFBR3L | TGFBRAP1 | TGIF1 | TGIF2 | TGIF2-RAB5IF | TGIF2LX | TGIF2LY | TGM1 | TGM2 | TGM3 | TGM4 | TGM5 | TGM6 | TGM7 | TGOLN2 | TGS1 | TH | TH2LCRR | THADA | THAP1 | THAP10 | THAP11 | THAP12 | THAP12P1 | THAP12P7 | THAP2 | THAP3 | THAP4 | THAP5 | THAP6 | THAP7 | THAP7-AS1 | THAP8 | THAP9 | THAP9-AS1 | THBD | THBS1 | THBS2 | THBS2-AS1 | THBS3 | THBS3-AS1 | THBS4 | THBS4-AS1 | THEG | THEG5 | THEGL | THEM4 | THEM5 | THEM6 | THEMIS | THEMIS2 | THG1L | Thioredoxin-disulfide reductase (TrxR) | THNSL1 | THNSL2 | THO complex | THOC1 | THOC2 | THOC3 | THOC5 | THOC6 | THOC7 | Thomsen-Friedenreich Antigen (CD176) | THOP1 | THORLNC | THPO | THRA | THRAP3 | THRB | Three amino acid loop extension transcription regulators | Threonine protease